These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 21947506)
1. Partial inactivation of CCR5- and CXCR4- tropic HIV-1 by human urine. Auvert B; Jenabian MA; Saidi H; Lissouba P; Bélec L Arch Virol; 2011 Dec; 156(12):2181-6. PubMed ID: 21947506 [TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products inhibit both infection and transmission in trans of HIV-1 from monocyte-derived dendritic cells to autologous T cells. Nasreddine N; Borde C; Gozlan J; Bélec L; Maréchal V; Hocini H J Immunol; 2011 May; 186(10):5687-95. PubMed ID: 21478402 [TBL] [Abstract][Full Text] [Related]
3. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. Yao Q; Compans RW; Chen C Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813 [TBL] [Abstract][Full Text] [Related]
4. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1. Joly M; Pinto JM Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340 [TBL] [Abstract][Full Text] [Related]
5. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection. Zaitseva MB; Lee S; Rabin RL; Tiffany HL; Farber JM; Peden KW; Murphy PM; Golding H J Immunol; 1998 Sep; 161(6):3103-13. PubMed ID: 9743377 [TBL] [Abstract][Full Text] [Related]
6. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection. Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658 [TBL] [Abstract][Full Text] [Related]
7. R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission. Saïdi H; Magri G; Nasreddine N; Réquena M; Bélec L Virology; 2007 Feb; 358(1):55-68. PubMed ID: 16934308 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians. Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992 [TBL] [Abstract][Full Text] [Related]
9. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Grivel JC; Ito Y; Fagà G; Santoro F; Shaheen F; Malnati MS; Fitzgerald W; Lusso P; Margolis L Nat Med; 2001 Nov; 7(11):1232-5. PubMed ID: 11689888 [TBL] [Abstract][Full Text] [Related]
10. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Chen Z; Gettie A; Ho DD; Marx PA Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999 [TBL] [Abstract][Full Text] [Related]
11. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines. Ito Y; Grivel JC; Chen S; Kiselyeva Y; Reichelderfer P; Margolis L J Infect Dis; 2004 Feb; 189(3):506-14. PubMed ID: 14745709 [TBL] [Abstract][Full Text] [Related]
12. Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. Asin SN; Fanger MW; Wildt-Perinic D; Ware PL; Wira CR; Howell AL J Infect Dis; 2004 Jul; 190(2):236-45. PubMed ID: 15216456 [TBL] [Abstract][Full Text] [Related]
13. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies. Ganesh L; Leung K; Loré K; Levin R; Panet A; Schwartz O; Koup RA; Nabel GJ J Virol; 2004 Nov; 78(21):11980-7. PubMed ID: 15479838 [TBL] [Abstract][Full Text] [Related]
14. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells. Xiao X; Kinter A; Broder CC; Dimitrov DS Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381 [TBL] [Abstract][Full Text] [Related]
15. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells. Bomsel M; Pastori C; Tudor D; Alberti C; Garcia S; Ferrari D; Lazzarin A; Lopalco L AIDS; 2007 Jan; 21(1):13-22. PubMed ID: 17148963 [TBL] [Abstract][Full Text] [Related]
16. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals. Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection. Moyle GJ; Wildfire A; Mandalia S; Mayer H; Goodrich J; Whitcomb J; Gazzard BG J Infect Dis; 2005 Mar; 191(6):866-72. PubMed ID: 15717260 [TBL] [Abstract][Full Text] [Related]
19. Effect of first, second, and third trimester placental factors on CD4, CCR5, and CXCR4 expression in human peripheral blood lymphocytes. Li LP; Kang JL; Xia W Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 33(6):461-7. PubMed ID: 18599991 [TBL] [Abstract][Full Text] [Related]
20. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones. Ariën KK; Gali Y; El-Abdellati A; Heyndrickx L; Janssens W; Vanham G Virology; 2006 Mar; 347(1):65-74. PubMed ID: 16386774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]